Patents by Inventor Kunzhong JIAN

Kunzhong JIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180327368
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: January 13, 2016
    Publication date: November 15, 2018
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDUSTRY LIAISON OFFICE, BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Raymond John ANDERSEN, Javier Garcia FERNANDEZ, Kunzhong JIAN, Marianne Dorothy SADAR, Nasrin R. MAWJI, Carmen Adriana BANUELOS
  • Publication number: 20180064657
    Abstract: Compounds having a structure of Formula I, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, L1, L2, L3, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: March 11, 2016
    Publication date: March 8, 2018
    Inventors: Raymond John ANDERSEN, Kunzhong JIAN, Marianne Dorothy SADAR, Nasrin R. MAWJI, Carmen Adriana BANUELOS
  • Publication number: 20170298033
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: April 17, 2017
    Publication date: October 19, 2017
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA, British Columbia Cancer Agency Branch
    Inventors: Raymond ANDERSEN, Marianne Dorothy SADAR, Kunzhong JIAN, Nasrin R. MAWJI, Jun WANG, Carmen Adriana BANUELOS, Yu-Chi YANG